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Abstract
Background: Chronic cough is a common condition, but some patients have no evident medical explanation for their
symptoms. A group of patients has been identified, characterized by upper and lower airway symptoms triggered by
chemicals and scents, and heightened cough sensitivity to inhaled capsaicin. Chronic cough is usually a prominent
symptom in these patients, and it has been suggested that they suffer from sensory hyperreactivity.
Our main aim was to analyse, in a group of patients with chronic cough, the presence of symptoms induced by
environmental factors such as chemicals, scents, and cold air, and to measure the social and emotional influences
of these symptoms in relation to quality of life. A second aim was to pilot-test a Swedish translation of a cough-
specific questionnaire.
Methods: A total of 119 patients with chronic cough were asked to answer three different questionnaires: a local
symptom questionnaire, the Chemical Sensitivity Scale for Sensory Hyperreactivity (CSS-SHR), and the Nottingham
Health Profile (NHP). In addition, a Swedish version of the Hull Airway Reflux Questionnaire (HARQ) was developed
and answered by a subgroup of patients and healthy controls.
Results: Sixty-two patients (52%) with mean cough duration of 10.6 years answered the local symptom questionnaire,
the CSS-SHR, and the NHP. Of these, 39 (63%) claimed to have cough and other symptoms induced by chemicals and
scents. Compared to population-based findings, the patients scored higher on the CSS-SHR, and the CSS-SHR score was
significantly higher among chemical-sensitive individuals (p < 0.001). The NHP showed that the patients had a
significantly reduced quality of life, which was most pronounced among chemical-sensitive individuals. The 31 patients
who answered the HARQ had significantly higher scores (p < 0.0001) than 59 healthy controls.
Conclusions: Among patients with chronic cough, a majority claimed that environmental factors induced
coughing. Both the CSS-SHR and the HARQ score systems seem to be valuable instruments in the mapping of
cough patients, supporting the novel paradigm of a cough hypersensitivity syndrome. Our results emphasize that
cough is a substantial burden to the patient, influencing daily living and quality of life.
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Background
Cough is an essential protective physiological mechanism
to prevent food, liquid, dust, and chemicals from reach-
ing the lower airways, but it is also a symptom of many
inflammatory diseases of the lungs. Coughing is one of
the commonest symptoms for which patients consult a
doctor in the western world, and current therapies are
often unsatisfactory [1]. Chronic cough is also clearly
associated with significant social and psychological
impacts [2,3]. Cough is arbitrarily defined as being
chronic when it has lasted for more than 8 weeks [4],
though the definition of chronic cough varies in the
l i t e r a t u r ea n dt h ep r e v a l e n c eo ft h i sc o n d i t i o nh a sb e e n
debated [4-6].
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tions, cancer, foreign body aspiration, cystic fibrosis, alveo-
litis, asthma, chronic obstructive pulmonary disease,
medication with angiotensin-converting enzyme (ACE)
inhibitor, gastro-oesophageal reflux disease (GERD), or
post-nasal drip syndrome have been excluded, a group of
patients with unexplained cough still remains. A discrete
clinical entity has been suggested for patients with such
chronic cough in combination with increased capsaicin
cough sensitivity, in which the cough is often triggered by
environmental stimuli, and furthermore, the cough initially
developed after an upper respiratory tract infection [7].
Some cough patients can be labelled as having chronic
refractory unexplained cough, a condition without medical
explanation and persistent, ongoing coughing in case of
thoroughly tries with different medications [6,8]. A similar
group of patients has been identified, characterized by
upper and lower airway symptoms triggered by chemicals
and scents, and heightened cough sensitivity to inhaled
capsaicin; it has been suggested that these patients suffer
from sensory hyperreactivity (SHR) [9,10]. The Hull
Airway Reflux Questionnaire (HARQ) was developed by
Morice et al. to identify coughers, with a novel paradigm
for understanding chronic cough [11]. This paradigm, the
‘cough hypersensitivity syndrome’, also includes patients
with symptoms that may indicate a reflux disease, such as
patients with a general hypersensitivity towards, for exam-
ple, environmental irritants. The patients are classified as
having a cough hypersensitivity syndrome that also com-
prises both sensitivity to environmental irritants and aug-
mented capsaicin cough response [12-14].
The extent to which chronic cough is caused by per-
ceived (hyper)sensitivity to chemicals and scents is not
well known. Furthermore, we do not know whether the
behavioural consequences and effects on health-related
quality of life (HRQoL) are influenced by the presence of
such hypersensitivity. These questions can, however, be
analysed by applying established and local questionnaires.
The Chemical Sensitivity Scale for Sensory Hyperreac-
tivity (CSS-SHR) was developed in order to quantify self-
reported affective reactions to, and behavioural disruptions
from, odorous/pungent substances [15]. It is useful for the
diagnosis of SHR, and a high CSS-SHR score is directly
related to capsaicin sensitivity [10].
The main aim of the present study was to analyse, in a
group of patients with chronic cough without evident
medical explanation, the presence of symptoms induced
by environmental factors such as chemicals, scents, cold
air, and exercise, and to measure the social and emotional
influences of these symptoms in relation to quality of life.
For this purpose a local questionnaire [16], the CSS-SHR
[15], and the Nottingham Health Profile (NHP) [17] were
used. A second aim was to pilot-test a Swedish translation
of the cough-specific questionnaire HARQ [11].
Methods
Patients
The patients were selected from the medical records at the
Department of Allergology and Respiratory Medicine at
the Sahlgrenska University Hospital in Gothenburg,
Sweden. Between January 2006 and December 2007, 479
patients attended the clinic due to chronic cough. From
this group, 119 patients, aged 18 to 74 years (68 women;
57%), were invited to participate. The patients had origin-
ally been referred to the clinic due to at least two months
of cough, and were diagnosed with chronic cough. Patients
with pulmonary or other diseases that could cause cough
were excluded, as were patients diagnosed with allergy,
rhinitis, post-nasal drip, or any kind of GERD. Other
exclusion criteria were any ACE inhibitors or medication
for GERD, and current smoking.
Study design
Part I
Three questionnaires (a local symptom questionnaire, the
CSS-CHR, and the NHP) were sent by postal mail to all
the patients, with a covering letter, informed consent
form, and a prepaid return envelope. The estimated time
to complete all three questionnaires was about 20 minutes.
The patients were reminded once within a month, with a
new letter and questionnaires. In some cases, after this,
patients were phoned for complementary answers.
The patients were asked to answer the questions based
on their experienced condition during the previous month.
Part II
A Swedish version of the HARQ was used as a pilot trial
[11]. Thirty-one patients (21 women; 68%) who had parti-
cipated in the first part of the study were consecutively
asked to also answer the HARQ questionnaire. They were
contacted by phone, and the questionnaire was then
mailed with a prepaid return envelope.
A control group of 59 (39 women; 66%) consecutively
selected, subjectively healthy, non-smoking individuals
also answered the HARQ. They were screened using ques-
tions on airway symptoms, symptoms of GERD, and
symptoms in response to chemicals, scents, cold air, and
exercise; none of the control group had any of these symp-
toms. The controls were subject to no further medical
examinations.
Questionnaires
Local symptom questionnaire
The local symptom questionnaire contained questions
concerning chemicals, scents, cold air, and exercise-
induced symptoms (yes/no). Thirteen symptoms were
analysed: cough, heavy breathing, difficulty getting air,
chest pressure, phlegm, throat irritation, hoarseness,
nasal blockage, rhinorrhoea, eye irritation, headache,
dizziness, and fatigue. The participants were asked to
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mild; 2, moderate; and 3, severe symptoms) [16].
CSS-SHR
The CSS-SHR questionnaire was used to quantify the
affective and behavioural consequences of self-reported
sensitivity to chemicals and scents in the course of daily
activities. The CSS-SHR is well validated and has a good
reproducibility [15]. It consists of 11 statements/questions
(see Additional file 1), selected from a large number of
items for measuring odour intolerance on the basis of
being particularly sensitive for discriminating patients with
SHR from healthy controls [18]. The unweighted sum of
all 11 items makes up the individual’s total CSS-SHR
score (0-54 points). A high score, ≥43 points, is regarded
as a diagnostic cut-off value for SHR [15]. In a random
general Swedish population of adults, the prevalence of
such odour intolerance, defined as a CSS-SHR score ≥43,
has been determined to be 19%, with an increased risk for
female gender (odds ratio: 2.3) [19].
NHP
Health-related quality of life was assessed using the NHP
questionnaire, which consists of two parts [17,20]. Norm
and reference values distributed for age and sex based on
data from larger population studies are used for both
part I and part II [17,21,22].
Part I contains 38 items covering six aspects of HRQoL,
concerning the domains of emotional reactions, sleep,
energy, pain, physical mobility, and social isolation. The
response alternatives for each item are ‘yes’ and ‘no’,
depending on whether that item fits the individual’s cur-
rent situation. The answers are weighted for each dimen-
sion, giving a range from zero (no problems at all) to 100
(presence of all problems within the area) [23].
Part II of the NHP contains seven questions, again with
yes/no alternatives, concerning the impact of health pro-
blems on the individual’s social functioning in terms of
paid employment, housework, social life, family life, sex
life, hobbies, and holidays. The proportions of positive
answers to each of the seven questions are calculated sepa-
rately and compared with the reference values.
HARQ
The HARQ [11] was originally derived from the Reflux
S y m p t o mI n d e xa n dm o d i f i e dt oa l l o wa n a l y s i so ft h e
symptomatology of reflux cough [24]. It was translated
from English to Swedish by bilingual personnel, using a for-
mal forward-backward translation, and two clinicians
reviewed the questions. The back translation was almost
identical to the source document. A preliminary Swedish
version was then determined. The HARQ is a self-adminis-
tered instrument, and consists of 14 items (see Additional
file 2). The participants were asked to evaluate how differ-
ent problems had affected them during the previous
month, on a scale of 0-5 (0, no problem; 5, severe/frequent
problems), with the total score varying from 0−70 points
and an upper normal total score limit of 13 points.
Statistical methods
All data were analysed using version 17 of the SPSS soft-
ware package (SPSS, Inc., Chicago, IL, USA). Data are
presented as mean values with standard deviation (SD),
a n dapv a l u eo f<0 . 0 5w a st a k e nf o rs t a t i s t i c a ls i g n i f i -
cance. For the local symptom questionnaire, the CSS-
SHR, and the HARQ, an independent t-test and the
Mann-Whitney U-test were applied for unpaired data,
and the chi-square test for categorical data. For the NHP,
the unpaired data in part I were analysed with the Mann-
Whitney U-test, and the chi-square test was used in part
II.
The ability of the HARQ to distinguish patients from
healthy controls was evaluated by constructing a receiver
operating characteristic (ROC) curve, and plotting the
sensitivity versus 1-specificity for each possible cut-off
score [25]. An area under the curve of more than 0.90
indicates that a method has outstanding discrimination
ability, for example the ability to distinguish two groups
from each other [26].
Informed consent was obtained from all participants
at the start of the investigation. The study was approved
by the Regional Ethical Review Board of Gothenburg,
Sweden.
Results
Part I
Seventy out of 119 patients completed all questionnaires,
giving a response rate of 59%. Six patients were excluded
from the analysis due to having recovered, and two due
to current smoking, leaving a total of 62 participants
(52%). Demographic data of the study group are shown
in table 1 and use of cough medication in table 2. All
ex-smokers had stopped smoking more than one year
earlier. Percentage distributions of reported trigger fac-
tors are shown in figure 1. There were no differences in
reported trigger factors between men and women.
Local symptom questionnaire
Except for cough, the most common symptoms and
symptoms with the highest scores were phlegm, throat
irritation, and fatigue. The patients’ symptom scores are
shown in figure 2.
Women reported more problems with eye irritation (p <
0.05) compared to men, but otherwise there were no dif-
ferences in symptoms between men and women.
Thirty-nine patients (63%; 27 women and 12 men
[ns]) claimed to have symptoms induced by chemical
and scent exposure. In the present article, these 39 are
defined as the chemical-sensitive group and patients
without chemical sensitivity as the non-sensitive group.
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with heavy breathing (p < 0.01), difficulty getting air (p <
0.01), chest pressure (p < 0.01), nasal blockage (p < 0.05),
eye irritation (p < 0.01), headache (p < 0.01), dizziness (p <
0.01), and fatigue (p < 0.001) compared to the non-sensi-
tive group.
CSS-SHR
The mean (SD) CSS-SHR score for the whole group was
38.7 (9.6). There were no differences in the scores between
men and women. The mean CSS-SHR score was 43.1 (6.5)
in the chemical-sensitive group compared to 31.2 (9.5) in
the non-sensitive group (p < 0.001).
Patients were divided into two groups according to the
cut-off value for CSS-SHR [15]: those with scores ≥43
points (high score) and those with scores < 43 points (low
score). Twenty-four patients (39%; 15 women) had a score
of ≥43 points. Of these, 21 belonged to the chemical-sensi-
tive group.
NHP
In part I of the NHP, the patients differed significantly
from the reference group in the areas of sleep (p < 0.01),
energy (p < 0.05), pain (p < 0.001), physical mobility (p <
0.001), and social isolation (p < 0.001). The chemical-
sensitive group had more problems in the areas of energy
(p < 0.01), pain (p < 0.01), and physical mobility (p <
0.001) compared to the non-sensitive group. Patients with
high CSS-SHR score experienced more HRQoL problems
with energy (p < 0.05), pain (p < 0.001), and physical
mobility (p < 0.05), compared to the low-scoring group.
In part II, the patients differed significantly from the
reference group in four of seven areas (Figure 3). The che-
mical-sensitive group had more problems than the non-
sensitive group in five of seven areas: paid employment
(p < 0.01), housework (p < 0.01), social life (p < 0.01), sex
life (p < 0.05), and holidays (p < 0.05). Patients with high
CSS-SHR score experienced more HRQoL problems than
the low-scoring group in five of seven areas: paid employ-
ment (p < 0.01), housework (p < 0.05), sex life (p < 0.05),
hobbies (p < 0.05), and holidays (p < 0.01).
There were no differences in HRQoL between genders.
Part II
HARQ
Fully completed questionnaires were obtained from 31
patients and 59 healthy controls. The two groups were
matched by gender, but not by age; mean age was 52.6
(12.8) years in the patient group, and 45.0 (14.7) years
among the controls (p < 0.01).
The mean total HARQ score was 17.0 (11.2) in the
patient group and 2.2 (3.0) among the controls (p <
0.0001). The cut-off limit of 13 points was exceeded by 16
patients (52%; 12 women), but in none of the healthy con-
trols. The area under the ROC curve was 0.92, which cor-
responds to outstanding discrimination ability (Figure 4).
Twenty-two patients (71%; 15 women) belonged to the
chemical-sensitive group. There were no differences in
HARQ score between these patients and the non-sensitive
group. Thirteen patients (42%; 9 women) belonged to the
group scoring high on the CSS-SHR. These patients
reported more problems with ‘c o u g hw i t hc e r t a i nf o o d ’
compared to the patients with low CSS-SHR scores
(p < 0.05).
Among the patients, the mean total score was 20.2
(10.0) for women and 11.0 (11.0) for men (p < 0.05). The
women also had significantly higher scores for ‘excess
mucus in the throat, or drip down the back of your nose’
(p < 0.05), ‘heartburn, indigestion, stomach acid coming
up’ (p < 0.05), ‘cough brought out by singing or speaking’
(p < 0.05), and ‘a strange taste in your mouth’ (p < 0.05)
compared to men. There were no gender differences
among the healthy controls.
Table 1 Demographic data for 62 patients with chronic
cough
Characteristics Subjects (n = 62)
Sex, female/male (n) 40/22
Age (years) 53.6 (11.9)
Duration of cough symptoms (years) 10.6 (10.0)
FEV1 % predicted 103.8 (16.9)
BMI (kg/m
2) 25.1 (4.8)
Smoking status (n)
Never/previous
38/24
Chest X-ray (n)
Normal/unknown
59/3
Methacholine provocation test (n)
Normal/unknown
52/10
Data are shown as mean and standard deviation (SD) for age, duration of
cough symptoms, FEV1, BMI, and otherwise as number (n).
Definition of abbreviations: FEV1 = Forced expiratory volume in one second;
BMI = Body mass index.
Table 2 Current or earlier use of medication for coughing in 62 patients with chronic cough
Medication Number of users (% of the whole group) Some effect Number (% of users)
Oral steroids 8 (13) 0
Inhaled corticosteroids 31 (50) 4 (13)
Inhaled b2 agonist 27 (44) 4 (15)
Inhaled anticholinergics 9 (15) 1 (11)
Morphine derivate syrup 16 (26) 13 (81)
Codeine 3 (5) 3 (100)
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The main findings in this study were that more than 60%
of the patients with chronic cough reported that coughing
could be induced by environmental factors like chemicals,
scents, exercise, and cold air, and that this coughing had a
negative impact on the patients’ health status and daily
lives. The patients had increased CSS-SHR and NHP
scores compared to population-based findings, and higher
total HARQ score compared to healthy controls.
About 40% of the chronic cough patients in this study
had a high CSS-SHR score (≥43 points), exceeding the
cut-off limit, which can be compared with a corresponding
value of 19% in a population-based study [19]. These
results indicate that SHR could be one explanation for the
reported symptoms. However, a standardized capsaicin
inhalation test would be required to diagnose whether
these patients actually did have SHR, and such a study is
planned. Earlier studies confirm that many patients with
SHR have symptoms similar to those of patients with
chronic cough [27-30].
The cough patients with chemical sensitivity reported
significantly more symptoms from the eyes, nose, and
lungs, as well as headache and fatigue, which is in accor-
dance with earlier results [19]. These findings, together
with the current results of impaired HRQoL among che-
mical-sensitive and high CSS-SHR scoring individuals,
may indicate a more troublesome form of cough. The
results can be compared with a recent study reporting a
median CSS-SHR score of 35 in a group of asthma
patients before treatment with inhaled corticosteroids,
in comparison to a score value of 25 in the control
group [31]. It is not known whether increased CSS-SHR
scores are also seen in other chronic conditions like irri-
table bowl syndrome and chronic pain, but it would be
of interest to study this in the future.
There were no differences in the CSS-SHR scores
between men and women, and women were not more
common in the high-scoring group, though women did
report more symptoms from the eyes compared to men.
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Figure 1 Percentage of positive responses of reported trigger
factors in 62 patients with chronic cough.
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Figure 2 Evaluation of nine symptoms on a scale of 0-3 (0, no
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Figure 4 ROC curve of ability to distinguish patients with
chronic cough from healthy controls.
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population, and on SHR, showing a dominance of women
with high CSS-SHR scores [15,19].
The chronic cough patients in the present study had sig-
nificantly impaired HRQoL compared with a population
sample, as assessed by the generic instrument NHP, and
also in comparison with other chronic conditions tested
with the NHP [32-34]. The findings are in accordance
with earlier studies in patients with SHR, also assessed
with the NHP [16,35]. There were no gender differences
in HRQoL; this is in contrast to other studies of patients
with chronic cough, which have shown women to be more
adversely affected than men regarding HRQoL in several
dimensions of daily life [36].
The preliminary Swedish version of the HARQ has not
yet been validated, and so cannot be used to draw any
major conclusions, though we hypothesise that the Swedish
translation will give results in concordance with the origi-
nal British version. However, the high HARQ scores in the
present study are striking, especially considering that the
questionnaire was originally constructed for patients with
cough and GERD, and patients with any history of reflux
symptoms or use of medication for such condition were
excluded from this study. This implies that the HARQ mir-
rors not only the symptoms of cough caused by GERD, but
also a hypersensitivity cough syndrome with other causes,
in agreement with earlier suggestions [11-13]. In accor-
dance with Morice et al., women with chronic cough had
significantly higher total scores compared to men, and the
area under the ROC showed outstanding discrimination
ability to distinguish patients from healthy controls [11]. In
future studies it will be crucial to make a formal validation
of the Swedish version of the HARQ, assessing repeatability
and validity.
Six patients were excluded from the data analysis because
they had recovered from their cough. Interestingly, none of
these patients reported airway sensitivity to chemicals and
scents. However, their number is too small to allow any
major conclusions as to whether chemical-induced symp-
toms could be an important factor for developing persistent
cough. A longitudinal study revealed that even after five
years, patients with cough and other airway symptoms
induced by chemicals and scents had lasting symptoms, a
reduced quality of life, and unchanged sensory hyperreac-
tivity, implying that the condition could be regarded as
chronic [16]. One challenge for the future will be to study
whether chemical sensitivity is crucial to the disease dura-
tion in a larger group of patients with chronic cough.
In recent years there has been emerging interest in the
family of transient receptor potential (TRP) ion channels.
These proteins are able to sense temperature, noxious
stimuli, pain, stretch, and osmolarity, among other fac-
tors. The main foci of such triggers in the airways are ion
channels belonging to the transient receptor potential
vanilloid (TRPV) and the transient receptor potential
ankyrin families [37-39]. Nociceptive sensory neurons
also participate in protective reflexes, including the
cough and sneeze reflexes, and release inflammatory neu-
ropeptides in the periphery upon stimulation by various
environmental stimuli. Patients with chronic cough have
been shown to have an increase in the transient receptor
potential vanilloid type 1 (TRPV1) staining nerve profiles,
and also a significant correlation between capsaicin tus-
sive response and the number of TRPV1-positive nerves
[40,41]. Several studies have shown that patients with
chronic cough have increased capsaicin sensitivity
[12,14]. The results from all these studies suggest that
the pathophysiology of chronic cough is related to airway
mucosal TRP receptors on sensory nerves, as well as
reaction to noxious stimuli [38]. This is in line with the
present finding that environmental triggers such as che-
micals and scents constitute a major cough trigger. The
related ion channel, the transient receptor potential mel-
astin type 8 (TRPM8), which is activated by menthol and
cold air, could be part of an explanation as to why a
majority of the study patients also reported cold air and
exercise as cough-inducing factors [42]. These results are
also in accordance with a recent study showing coughing
and increased cough sensitivity in patients with SHR
after provocations with exercise in cold air [30].
In summary, our results underline the importance of
widening the views regarding chronic cough. Both the
CSS-SHR and the HARQ score system turned out to be
valuable instruments in the mapping of cough patients,
supporting the novel paradigm of a cough hypersensitiv-
ity syndrome. The study also once more emphasizes
that cough is a substantial burden to the patient, influ-
encing daily life and HRQoL.
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